ES360000A1 - Un procedimiento para la preparacion de compuestos de 2-7- diamino-6-arilpirido (2,3-d) pirimidina. - Google Patents

Un procedimiento para la preparacion de compuestos de 2-7- diamino-6-arilpirido (2,3-d) pirimidina.

Info

Publication number
ES360000A1
ES360000A1 ES360000A ES360000A ES360000A1 ES 360000 A1 ES360000 A1 ES 360000A1 ES 360000 A ES360000 A ES 360000A ES 360000 A ES360000 A ES 360000A ES 360000 A1 ES360000 A1 ES 360000A1
Authority
ES
Spain
Prior art keywords
pyrimidine
amino
compound
reacting
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES360000A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parke Davis and Co LLC
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Publication of ES360000A1 publication Critical patent/ES360000A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES360000A 1967-11-09 1968-11-08 Un procedimiento para la preparacion de compuestos de 2-7- diamino-6-arilpirido (2,3-d) pirimidina. Expired ES360000A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51042/67A GB1171218A (en) 1967-11-09 1967-11-09 New Heterocyclic Amine Compounds and Methods for their Production

Publications (1)

Publication Number Publication Date
ES360000A1 true ES360000A1 (es) 1970-06-16

Family

ID=10458417

Family Applications (1)

Application Number Title Priority Date Filing Date
ES360000A Expired ES360000A1 (es) 1967-11-09 1968-11-08 Un procedimiento para la preparacion de compuestos de 2-7- diamino-6-arilpirido (2,3-d) pirimidina.

Country Status (10)

Country Link
US (1) US3534039A (es)
JP (4) JPS4821119B1 (es)
BE (1) BE723660A (es)
CH (1) CH500204A (es)
DE (1) DE1807887A1 (es)
ES (1) ES360000A1 (es)
FR (2) FR1594755A (es)
GB (1) GB1171218A (es)
NL (1) NL6815963A (es)
SE (1) SE340813B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3939268A (en) * 1971-04-10 1976-02-17 Boehringer Ingelheim Gmbh 2,4-Diamino substituted pyridol(3,2-d)pyrimidine as antithrombotic agents
US4271164A (en) * 1979-04-16 1981-06-02 Warner-Lambert Company 6-Substituted-arylpyrido[2,3-d]pyrimidin-7-amines and derivatives
IL115256A0 (en) * 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
ES2146782T3 (es) * 1994-11-14 2000-08-16 Warner Lambert Co 6-aril-pirido(2,3-d)pirimidinas y naftiridinas para la inhibicion de la proliferacion celular inducida por la proteina tirosina quinasa.
US5620981A (en) * 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
IL117923A (en) * 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US5945422A (en) * 1997-02-05 1999-08-31 Warner-Lambert Company N-oxides of amino containing pyrido 2,3-D! pyrimidines
NZ502704A (en) * 1997-08-20 2002-06-28 Warner Lambert Co Naphthyridinones and pharmaceuticals thereof and their use in inhibiting cellular proliferation and protein tyrosine kinase or cell cycle kinase enzymatic activity
US20050009849A1 (en) * 2003-01-03 2005-01-13 Veach Darren R. Pyridopyrimidine kinase inhibitors
FR2873118B1 (fr) * 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) * 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
FR2910813B1 (fr) * 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3021332A (en) * 1954-01-04 1962-02-13 Burroughs Wellcome Co Pyrido (2, 3-d) pyrimidine compounds and method of making

Also Published As

Publication number Publication date
SE340813B (es) 1971-12-06
FR1594755A (es) 1970-06-08
JPS4826040B1 (es) 1973-08-03
CH500204A (fr) 1970-12-15
JPS4821119B1 (es) 1973-06-26
US3534039A (en) 1970-10-13
NL6815963A (es) 1969-05-13
JPS4826039B1 (es) 1973-08-03
JPS4821120B1 (es) 1973-06-26
DE1807887A1 (de) 1970-05-21
FR8247M (es) 1970-10-12
BE723660A (es) 1969-04-16
GB1171218A (en) 1969-11-19

Similar Documents

Publication Publication Date Title
ES360000A1 (es) Un procedimiento para la preparacion de compuestos de 2-7- diamino-6-arilpirido (2,3-d) pirimidina.
Jones Studies on imidazole compounds. I. A synthesis of imidazoles with functional groups in the 2-position
GB1327312A (en) Hererocyclic compounds
Vereshchagin et al. Electrocatalytic and chemical methods in MHIRC reactions: the first example of the multicomponent assembly of medicinally relevant spirocyclopropylbarbiturates from three different molecules
GB1351430A (en) Substituted 1,2,4-triazole derivatives
GB1359563A (en) Pyrazolo-pyrimidines useful as xanthine oxidase inhibitors
GB1054833A (es)
GB1382513A (en) 1-pyridylalkyl-indole derivatives
GB1188956A (en) N-Substituted Aromatic Amidines and process for obtaining same
GB1373548A (en) Anti-hypertensive 6-substituted 3-hydrazino-pyridazines and their preparation
GB1452545A (en) Phenylarylalkyl derivtives and their use as pesticides
GB1513742A (en) 6-aryl-2,3,6,7-tetrahydro-5h-pyrrolo(1,2-a)imidazole derivatives processes for their manufacture and compositions containing them
US3287468A (en) 2-nitroimidazoles and process
GB1413262A (en) 2-phenoxyalkylthio imidazoles and congeners
GB1429654A (en) Oxime and hydrazine derivatives of phenylketones and their production
GB1397869A (en) 1,8-naphthyridin derivatives
GB1108288A (en) Improvements in or relating to pyrimidine compounds
JPS57188569A (en) Preparation of piperidino-propanol derivative
GB1167262A (en) 0-Sulphonyl-5,5-Disubstituted-Hydantoins and process for preparation thereof
GB1141862A (en) Substituted imidazoles and their preparation
GB1394620A (en) 1,3,5-trisubstituted triazoles
GB1355993A (en) Prostaglandins and their preparation
GB1229170A (es)
GB1183673A (en) Novel Quinazolinone Derivatives
SU1553013A3 (ru) Способ получени 9-(1,3-диадамантилкарбокси-2-пропоксиметил)гуанина